BTL Files Complaint with ITC to Prevent Unlawful Importation of Body Contouring Products

August 7, 2020

BTL Industries, Inc., the manufacturer of the Emsculpt body-contouring device and other products for non-invasive body-shaping procedures, has filed a complaint with the United States International Trade Commission (ITC) asking the Commission to prevent Allergan Limited, Allergan, Inc., Allergan USA Inc., Zeltiq Aesthetics, Inc., Zeltiq Ireland Unlimited Company (Allergan), and Zimmer MedizinSysteme GmbH, Germany (Zimmer) from importing products that infringe BTL’s patents into the United States. BTL concurrently filed a lawsuit with the U.S. Federal District Court in the District of Delaware against Allergan and Zimmer on the same matter.
The ITC is an independent, quasi-judicial federal agency with broad investigative responsibilities on matters that affect trade and commerce, including intellectual property infringement.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • AmSpa CEO Reflects on the Sonya Dakar Case
    • SkinStylus Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types
    • GlossGenius Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • FDA Advisory Committee to Review Seven Peptides for Potential Use in Compounding
    • Medicare GLP-1 Bridge Program Launches July 1, Expanding Access for Some Patients